CClinicalTrials.gg
CompletedNCT05450731Updated Feb 20, 2024

Cardiac Rehab Post-atrial Fib Ablation

An interventional study of 12-week supervised exercise based cardiac rehabilitation program in Atrial Fibrillation, sponsored by MultiCare Health System Research Institute. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-02-20.

Sponsored by MultiCare Health System Research Institute · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to examine the effect of a 12-week exercise-based cardiac rehabilitation intervention on the recurrence of atrial fibrillation (AF) in patients at six- and twelve-months post-ablation procedure.

02

Conditions studied

  • Atrial Fibrillation

Browse trials for

03

In context

Atrial Fibrillation

3,870 studies on the registry are indexed under Atrial Fibrillation; 924 are open to participants now.

This study's enrollment of 40 is below the median of 144 across 2,380 interventional studies indexed under Atrial Fibrillation.

Browse Atrial Fibrillation studies →

Lead sponsor

MultiCare Health System Research Institute is the lead sponsor of 14 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • ● Adult patients 18 years and older.

    • Willing to participate in the study after randomization to either an intervention group (cardiac rehabilitation exercise) or a control group (usual care).
    • Able to attend two pre and post study clinic visits at a local designated Pulse Heart Institute cardiac rehab program.
    • If randomized to the cardiac rehab intervention group can attend exercise rehab visits for 3 x per week for 12 weeks (36 visits) at a designated Pulse cardiac rehab program.
    • Has an active email address and phone number.
    • Documented diagnosis of Paroxysmal and persistent Atrial Fibrillation.
    • Undergone ablation treatment and is at a minimum of 2 weeks post ablation status.
    • Compliant with medication therapy including medications for heart rate control and anticoagulant(s).

Exclusion criteria

Exclusion Criteria:

  • ● Does not speak English.

    • Does not have clearance to participate in the study by their attending cardiologist.
    • Documented cardiovascular disease or pulmonary/respiratory disease that would qualify the patient for Cardiac, Pulmonary or Vascular Rehabilitation at a Pulse Heart Institute rehabilitation program.
    • Dementia or cognitive impairment.
    • Unable to participate in rehabilitation exercise due to physical limitations.
    • Greater than one prior ablation procedure
    • Long standing, chronic Atrial Fibrillation
    • Patients who have undergone posterior wall isolation ablation.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    cardiac rehabilitation intervention group

    Participants assigned to the intervention group will participate in pre-post assessments and a 12-week supervised exercise based cardiac rehabilitation program at a designated local Pulse Heart Institute Cardiac Rehabilitation program.

    Other: 12-week supervised exercise based cardiac rehabilitation program

  • No intervention
    control group

    Participants assigned to the control group will participate in pre-post assessments and will maintain usual care and current activity levels.

Interventions

  • Other12-week supervised exercise based cardiac rehabilitation program

    12-week exercise-based cardiac rehabilitation intervention on the recurrence of atrial fibrillation (AF) in patients at six- and twelve-months post-ablation procedure.

06

What researchers measure

Primary outcomes

  1. The aim of this study is to examine the effect of a 12-week exercise-based cardiac rehabilitation intervention on the recurrence of atrial fibrillation (AF) in 40 patients at six- and twelve-months post-ablation procedure.

    Examine the effect of a 12-week exercise-based cardiac rehabilitation intervention on the recurrence of atrial fibrillation at 6- and 12-months post-ablation treatment.

    Time frame: 12 months after the first intake appointment

07

Study locations

1 site
  • Tacoma General Hospital
    Tacoma, Washington 98415, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05450731
Lead sponsor
MultiCare Health System Research Institute
Responsible party
Sponsor
First posted
Jul 11, 2022
Start date
May 14, 2022
Primary completion
Jun 14, 2023
Completion
Jan 13, 2024
Last update
Feb 20, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion